Lumira Ventures
David Novak is a Venture Partner at Lumira Ventures, a position held since 2022. Prior to this role, David served as Managing Director and Equity Research Analyst for Healthcare & Biotechnology at Raymond James from 2018 to 2022 and was an Equity Research Analyst in the same sector at Cormark Securities from 2015 to 2018. Earlier experience includes a tenure as Vice President, Equity Research Analyst at Clarus Securities Inc. in 2014-2015 and as a Contract Scientific Diligence Analyst at Bloom Burton & Co. in 2013. David's scientific background encompasses work as a Geneticist at GeneNews Corporation from 2011 to 2013, where expertise in biomarkers was developed, and research roles at McGill University Health Centre from 2005 to 2010, focusing on cancer susceptibility and therapeutic agents. David holds both an MSc in Human Medical Genetics and a BSc in Molecular Biology from McGill University.
This person is not in any teams
This person is not in any offices
Lumira Ventures
Lumira Ventures is a leading healthcare and life sciences venture capital firm, investing in innovative entrepreneurs developing best and first-in-class therapeutics & medical technologies across North America. We are engaged partners who support the management teams of companies we invest in to build products that have the potential to allow people to lead fundamentally healthier, longer, and more productive lives.